Ottawa – April 24, 2023 – The Canadian Centre for Ethics in Sport (CCES) announced today that under the rules of the Canadian Anti-Doping Program (CADP), it has asserted two anti-doping rule violations against Dimitrios Papanikolaou, a U SPORTS football athlete affiliated with McGill University. The athlete’s urine samples, collected in-competition on October 23, 2021 and out-of-competition on October 13, 2022, both revealed the presence of SARM LGD-4033, a prohibited anabolic agent.
In accordance with the rules of the CADP, the athlete has requested a hearing to contest the applicable sanctions in relation to both anti-doping rule violations, which he has admitted. The athlete is currently serving a provisional suspension pending the outcome of a hearing scheduled for May 3 and 4, 2023.
Rule 14.3.1 of the CADP provides the CCES with the authority to publicly disclose the identity of an athlete against whom the CCES has asserted an anti-doping rule violation and whether the athlete is subject to a provisional suspension. The CCES has exercised this authority given that the athlete is eligible for the Canadian Football League’s (CFL) draft on May 2, 2023.
About the CCES
The CCES works collaboratively to ensure Canadians have a positive sport experience. Through its programs, the CCES manages unethical issues in sport, protects the integrity of Canadian sport, and promotes True Sport to activate values-based sport on and off the field of play. The CCES is an independent, national, not-for profit organization that is responsible for the administration of the CADP. Under the CADP rules, the CCES makes public every anti-doping rule violation. For more information, visit cces.ca, follow us on Twitter, Facebook, or Instagram.